These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 26582203)
41. Biochemical and functional characterization of the human tissue kallikrein 9. Filippou PS; Farkona S; Brinc D; Yu Y; Prassas I; Diamandis EP Biochem J; 2017 Jul; 474(14):2417-2433. PubMed ID: 28559305 [TBL] [Abstract][Full Text] [Related]
42. Purification and characterization of active recombinant rat kallikrein rK9. Zani M; Brillard-Bourdet M; Lazure C; Juliano L; Courty Y; Gauthier F; Moreau T Biochim Biophys Acta; 2001 Jun; 1547(2):387-96. PubMed ID: 11410295 [TBL] [Abstract][Full Text] [Related]
43. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230 [TBL] [Abstract][Full Text] [Related]
44. Human tissue kallikreins: the cancer biomarker family. Paliouras M; Borgono C; Diamandis EP Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179 [TBL] [Abstract][Full Text] [Related]
45. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids. Yousef GM; Kapadia C; Polymeris ME; Borgono C; Hutchinson S; Wasney GA; Soosaipillai A; Diamandis EP Biochim Biophys Acta; 2003 Jul; 1628(2):88-96. PubMed ID: 12890555 [TBL] [Abstract][Full Text] [Related]
46. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors. Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561 [TBL] [Abstract][Full Text] [Related]
47. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates. McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185 [TBL] [Abstract][Full Text] [Related]
48. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417 [TBL] [Abstract][Full Text] [Related]
49. Structural determinants of the half-life and cleavage site preference in the autolytic inactivation of chymotrypsin. Bódi A; Kaslik G; Venekei I; Gráf L Eur J Biochem; 2001 Dec; 268(23):6238-46. PubMed ID: 11733020 [TBL] [Abstract][Full Text] [Related]
51. Identifying the combination of the transcriptional regulatory sequences on prostate specific antigen and human glandular kallikrein genes. Tsui KH; Wu L; Chang PL; Hsieh ML; Juang HH J Urol; 2004 Nov; 172(5 Pt 1):2029-34. PubMed ID: 15540783 [TBL] [Abstract][Full Text] [Related]
52. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. Debela M; Magdolen V; Grimminger V; Sommerhoff C; Messerschmidt A; Huber R; Friedrich R; Bode W; Goettig P J Mol Biol; 2006 Oct; 362(5):1094-107. PubMed ID: 16950394 [TBL] [Abstract][Full Text] [Related]
53. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution. Katz BA; Liu B; Barnes M; Springman EB Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894 [TBL] [Abstract][Full Text] [Related]
54. Increased glycosylation efficiency of recombinant proteins in Escherichia coli by auto-induction. Ding N; Yang C; Sun S; Han L; Ruan Y; Guo L; Hu X; Zhang J Biochem Biophys Res Commun; 2017 Mar; 485(1):138-143. PubMed ID: 28188786 [TBL] [Abstract][Full Text] [Related]
56. Expression of a kallikrein-like protease from the snake venom: engineering of autocatalytic site in the fusion protein to facilitate protein refolding. Hung CC; Chiou SH Biochem Biophys Res Commun; 2000 Sep; 275(3):924-30. PubMed ID: 10973823 [TBL] [Abstract][Full Text] [Related]
58. The autolytic regulation of human kallikrein-related peptidase 6. Blaber SI; Yoon H; Scarisbrick IA; Juliano MA; Blaber M Biochemistry; 2007 May; 46(17):5209-17. PubMed ID: 17417874 [TBL] [Abstract][Full Text] [Related]
59. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein. El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709 [TBL] [Abstract][Full Text] [Related]